[Retracted] Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients

Table 2

The correlation between clinical or histopathological characteristics and 14-3-3 expression in 65 extrahepatic cholangiocarcinoma.

	14-3-3δ expression
	Total	Negative	Positive	value
Gender (%)
Male	37 (56.9)	6 (50)	31 (58.5)	NS
Female	28 (43.1)	6 (50)	22 (41.5)
Age (%)
≥65 years	22 (33.8)	4 (33.3)	18 (33.9)	NS
<65 years	43 (66.2)	8 (66.7)	35 (66.1)
Tumour size (%)
>2.5 cm	45 (69.2)	10 (83.3)	35 (66.0)	NS
≤2.5 cm	20 (30.8)	2 (16.7)	18 (34.0)
Pathologic differentiation (%)
Well	30 (46.2)	5 (41.6)	25 (16.7)	NS
Moderate	29 (44.6)	6 (50)	23 (16.7)
Poor	6 (9.2)	1 (8.4)	5 (16.7)
Lymphatic permeation (%)
No	32 (49.2)	10 (75)	22 (43.4)	0.011
Yes	33 (50.8)	2 (25)	31 (56.6)
Tumor stage (%)
I+II	25 (38.5)	8 (66.7)	17 (32.1)	0.046
III+IV	40 (61.5)	4 (33.3)	36 (67.9)

NS: not significant.